Dipyridamole preconditioning protects against ischemia/reperfusion injury of rat liver

Chinese Critical Care Medicine

Volumn 18, Issue 7, 2006, Pages 425-427

  Hong, Yong ^a   Liao, Wen Sheng ^a   Mo, Rui Xiang ^a  

^a GUILIN MEDICAL UNIVERSITY   (China)

Author keywords

Adenosine; Dipyridamole; Hepatic ischemia reperfusion injury

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE PHOSPHATE; ADENOSINE TRIPHOSPHATE; ALANINE AMINOTRANSFERASE; DIPYRIDAMOLE; ENDOTHELIN 1; LACTATE DEHYDROGENASE; TUMOR NECROSIS FACTOR ALPHA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; ENZYME ACTIVITY; HISTOPATHOLOGY; ISCHEMIC PRECONDITIONING; LACTATE DEHYDROGENASE BLOOD LEVEL; LIVER INJURY; LIVER ISCHEMIA; LIVER PROTECTION; NONHUMAN; PORTAL VEIN; PROTEIN BLOOD LEVEL; RAT; RAT STRAIN; REPERFUSION INJURY; TISSUE LEVEL;

ANIMALS; DIPYRIDAMOLE; DISEASE MODELS, ANIMAL; FEMALE; ISCHEMIC PRECONDITIONING; LIVER; MALE; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY;

EID: 33746490102     PISSN: 10030603     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Chinese source. 1992, 17:81-83.
2. Grace P A. Ischaemia-reperfusion injury[J]. Br J Surg, 1994, 81: 637-647.
3. Granger D N, Korthuis R J. Physiologic mechanisms of postischemic tissue injury[J]. Annu Rev Physiol, 1995, 57: 311-312.
4. Howell J G, Zibari G B, Brown M F, et al. Both ischemic and pharmacological preconditioning decrease hepatic leukocyte/endothelial cell interactions [J]. Transplantation, 2000, 69: 300-303.
5. Chinese source. 2000, 12:217-219.
6. Chinese source. 2002, 14:217-219.
7. Chinese source. 2004, 16:158-160.
8. Miura T, Ogawa T, Iwamoto T, et al. Dipyridamole potentiates the myocardial infarct size-limiting effect of ischemic, preconditioning[J]. Circulation, 1992, 86:979-985.